863976-76-5

Upstream product

• 161561-86-0 (S)-6-{[(tert-butyldiphenylsilyl)oxy]methyl}-5,6-dihydro-2H-pyran-2-one 

Downstream Products

• 863976-75-4 (2R,3R,4S,6S)-3-acetoxy-4-(tert-butoxycarbonylamino)-6-[(tert-butyldiphenylsilyloxy)methyl]-2-methoxytetrahydro-2H-pyran 
• 863976-81-2 (2R,3R,4S,6S)-3-acetoxy-4-azido-6-[(tert-butyldiphenylsilyloxy)methyl]-2-methoxytetrahydro-2H-pyran 
• 863976-80-1 (2R,3R,4R,6S)-3-acetoxy-6-[(tert-butyldiphenylsilyloxy)methyl]-4-hydroxy-2-methoxytetrahydro-2H-pyran 
• 863976-78-7 tert-butyl[{(3aR,4R,6S,7aR)-4-methoxy-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-6-yl}methoxy]diphenylsilane 
• 863976-79-8 (2R,3R,4R,6S)-6-[(tert-butyldiphenylsilyloxy)methyl]-2-methoxytetrahydro-2H-pyran-3,4-diol 
• 863976-77-6 (3aR,6S,7aR)-6-[(tert-butyldiphenylsilyloxy)methyl]-2,2-dimethyldihydro-3aH-[1,3]dioxolo[4,5-c]pyran-4(6H)-one 

Relevant academic research and scientific papers

Stereoselective route to the ezoaminuroic acid core of the ezomycins

Starting from readily available (R)-glycidol, an efficient pathway to a strategically functionalized ezoaminuroic acid derivative of the antifungal ezomycins has been developed. A key transformation in the synthesis involves regio- and stereoselective con